News

Rheumatoid arthritis patients and rheumatology providers share many of the same concerns over obstacles that make it harder to reach treat-to-target goals, according to a new study.

Risankizumab (Skyrizi) is now approved for treating moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

The COAST-X trial evaluated the safety and efficacy of ixekizumab for the treatment of non-radiographic axial spondyloarthritis (nr-axSpA).

A trial of 172 patients with knee pain from osteoarthritis, shows that the active component of chili peppers called capsaicin, successfully and significantly reduced pain intensity. 

Axial spondyloarthritis (axSpA) is never a straightforward diagnosis. In this slideshow, we highlight 11 disease manifestations associated with axSpA.

Robert Terkeltaub M.D., the rheumatology section chief of the VA Medical Center in San Diego and the corresponding author of the first-ever treatment guidelines for gout by the American College of Rheumatology, recently spoke with Rheumatology Network about updates in gout treatment.

The study also found that the overall rate of cardiovascular events was low in the study population, indicating that statins aren’t required for all RA patients.

Mortality rates for white, African American and Hispanic patients with end stage lupus-related renal disease are down. The findings contradict a previous analysis conducted in 2006.

Patients with systemic lupus erythematosus often have a range of clinical symptoms that are nonspecific and overlap with other medical conditions, such as Sjögren’s syndrome, rheumatoid arthritis and Raynaud's syndrome.

Delays in diagnosing axSpA are troubling, write the authors of a report in the journal Rheumatology. Delays of up to 10 years have been reported. Not all physicians may be familiar with the signs and symptoms of axSpA.

Physiotherapy, exercise and pain medications should be part of the treatment plan to improve the quality of life of patients suffering from stiffness associated with axial spondyloarthritis.

Osteoarthritis and rheumatoid arthritis patients report having similar pain levels in the beginning, but by six months, osteoarthritis patients say their pain is worse. This suggests a need for more effective osteoarthritis treatments, say researchers writing in Arthritis & Rheumatology. In this Q&A, the study’s lead author, Theodore Pincus, M.D., of Rush University Medical Center in Chicago, shares his findings with us.

A new systematic review and meta-analysis shows that while NSAIDs peaks at two weeks, while gastrointestinal and cardiovascular adverse events linger.

The therapy will carry a one-year treatment advisory and boxed warning on its label for cardiovascular risks.

Study shows there is no substantial difference in cardiovascular risk associated with different biologic therapies for psoriasis and psoriatic arthritis patients.

When it comes to reducing the risk of gout flares, dietary sources of omega-3 polyunsaturated fatty acids may be superior to supplements, shows a new study.

In chronic low back pain patients, spinal manipulation therapy can be equally effective at relieving pain and better at providing short-term function improvement compared to recommended treatments, according to recent research.

An aging US population, plus minimal non-invasive alternative options, determine the rate and scope of work an orthopedic surgeon sees today.

The potential for intervening in bone loss due to aging may require a broader approach to the interactions of both the hematopoietic and skeletal systems.

Intra-articular hyaluronic acid may be suitable as treatment for knee osteoarthritis, a review shows. The findings are inconsistent with many of the clinical guidelines.

An editorial in today's issue of Rheumatology makes a strong case for trying subcutaneous methotrexate first before a biologic.

Growth of bacteria in the intestinal tract is associated with increased lupus activity, particularly lupus nephritis, according to recent research.

Certolizumab pegol (Cimzia) is the first FDA-approved treatment for the condition.

Burnout affects 42 percent of doctors, a survey shows. Loss of patient trust has been identified as a casualty of burnout.

How well do you know the ACR treatment recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis? Test your knowledge with this quiz.

Electronic health records data can be used to create forecast models of disease outcomes in rheumatoid arthritis patients, according to new research.

Reproductive-age female patients face potential pregnancy complications, but rheumatologists rarely discuss family planning. New research reveals barriers preventing rheumatologists from starting these conversations.

There are a number treatment options for acute gout flares, but only one mainstay to prevent flares. In this article, we review treatment options.

Shoulder replacement in arthritis patients has increased in recent decades, but research shows that more replacements fail than previously thought, requiring more revision surgeries.

The cause of discovertebral lesions in ankylosing spondylitis may be due to infectious, inflammatory or traumatic etiologies suggest researchers writing in the Journal of Rheumatology. They examined the most prevalent-and conflicting-theories associated with this medical mystery.